Will CVS Health Stock Recover?
It’s been a treacherous journey for CVS Health Corporation (NYSE:CVS)…
Buy
56
LULU Quote, Financials, Valuation and Earnings
Last price:
$373.74
Seasonality move
:
11.92%
Day range:
$373.04 - $378.53
52-week range:
$226.01 - $491.30
Dividend yield:
0%
P/E ratio:
27.00x
P/S ratio:
4.59x
P/B ratio:
11.42x
Volume:
1.3M
Avg. volume:
2.1M
1-year change:
-20.22%
Market cap:
$45.5B
Revenue:
$9.6B
EPS (TTM):
$13.84
Analysts' Opinion
-
Consensus RatingLululemon Athletica has received a consensus rating of Buy. The company's average rating is a Buy based on 17 Buy ratings, 10 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $395.43, Lululemon Athletica has an estimated upside of 5.82% from its current price of $373.70.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $194.00 representing 48.09% downside risk from its current price of $373.70.
Fair Value
-
According to the consensus of 28 analysts, Lululemon Athletica has 5.82% upside to fair value with a price target of $395.43 per share.
LULU vs. S&P 500
-
Over the past 5 trading days, Lululemon Athletica has underperformed the S&P 500 by -8.18% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lululemon Athletica does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lululemon Athletica has grown year-over-year revenues for 18 quarters straight. In the most recent quarter Lululemon Athletica reported revenues of $2.4B.
Earnings Growth
-
Lululemon Athletica has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Lululemon Athletica reported earnings per share of $2.87.
Enterprise value:
44.3B
EV / Invested capital:
--
Price / LTM sales:
4.59x
EV / EBIT:
18.64x
EV / Revenue:
4.35x
PEG ratio (5yr expected):
0.35x
EV / Free cash flow:
27.79x
Price / Operating cash flow:
29.33x
Enterprise value / EBITDA:
15.87x
Gross Profit (TTM):
$6B
Return On Assets:
25.7%
Net Income Margin (TTM):
17.05%
Return On Equity:
43.4%
Return On Invested Capital:
43.4%
Operating Margin:
20.47%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $7.5B | $9.2B | $10.2B | $2.2B | $2.4B | |
| Gross Profit | $4.2B | $5.2B | $6B | $1.3B | $1.4B | |
| Operating Income | $1.6B | $2B | $2.4B | $412.6M | $490.7M | |
| EBITDA | $1.9B | $2.4B | $2.8B | $510.6M | $604.3M | |
| Diluted EPS | $9.10 | $7.86 | $13.84 | $1.96 | $2.87 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.6B | $2.3B | $2.6B | $3.4B | $3.6B | |
| Total Assets | $3.6B | $4.6B | $5.3B | $6B | $7.1B | |
| Current Liabilities | $730.9M | $1.1B | $1.3B | $1.4B | $1.8B | |
| Total Liabilities | $1.5B | $1.9B | $2.3B | $2.5B | $3.1B | |
| Total Equity | $2.2B | $2.7B | $3B | $3.5B | $4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $651.2M | $2B | $2.3B | $389.9M | $300.7M | |
| Cash From Investing | -$501.3M | -$628.4M | -$784M | -$161.7M | -$308.6M | |
| Cash From Financing | -$721.2M | -$578.6M | -$1.4B | -$204.9M | -$412M | |
| Free Cash Flow | $92M | $1.3B | $1.6B | $227M | $122.2M | |
LULU
Sector
Market Cap
$45.5B
$465.6M
Price % of 52-Week High
76.06%
72.07%
Dividend Yield
0%
0%
Shareholder Yield
3.73%
3.59%
1-Year Price Total Return
-20.22%
-9.69%
Beta (5-Year)
1.180
0.958
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$386.35
200-day SMA
Buy
Level
$312.55
Bollinger Bands (100)
Buy
Level
267.18 - 366.36
Chaikin Money Flow
Buy
Level
98.8M
20-day SMA
Sell
Level
$383.49
Relative Strength Index (RSI14)
Sell
Level
48.07
ADX Line
Buy
Level
19.65
Williams %R
Buy
Level
-86.2597
50-day SMA
Buy
Level
$358.13
MACD (12, 26)
Buy
Level
5.44
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
304.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (15.5862)
Buy
CA Score
(Annual)
Level (2.0703)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.6143)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 700 company-owned stores in about 20 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Stock Forecast FAQ
In the current month, LULU has received 17 Buy ratings 10 Hold ratings, and 1 Sell ratings. The LULU average analyst price target in the past 3 months is $395.43.
-
Where Will Lululemon Athletica Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lululemon Athletica share price will rise to $395.43 per share over the next 12 months.
-
What Do Analysts Say About Lululemon Athletica?
Analysts are divided on their view about Lululemon Athletica share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lululemon Athletica is a Sell and believe this share price will drop from its current level to $194.00.
-
What Is Lululemon Athletica's Price Target?
The price target for Lululemon Athletica over the next 1-year time period is forecast to be $395.43 according to 28 Wall Street analysts, 17 of them rate the stock a Buy, 1 rates the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is LULU A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lululemon Athletica is a Buy. 17 of 28 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LULU?
You can purchase shares of Lululemon Athletica via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lululemon Athletica shares.
-
What Is The Lululemon Athletica Share Price Today?
Lululemon Athletica was last trading at $373.74 per share. This represents the most recent stock quote for Lululemon Athletica. Yesterday, Lululemon Athletica closed at $373.70 per share.
-
How To Buy Lululemon Athletica Stock Online?
In order to purchase Lululemon Athletica stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
